Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Antipsychotic Medication Administered Without Proper Diagnosis

Weslaco, Texas Survey Completed on 05-14-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident’s drug regimen was free from unnecessary drugs by administering Seroquel (quetiapine), an antipsychotic medication, without a proper diagnosis supporting its use. The resident in question had a diagnosis of unspecified dementia without behavioral or psychotic disturbances, as well as hallucinations, but the documentation did not indicate behavioral symptoms that would warrant antipsychotic therapy. The care plan and medical records showed the medication was ordered for 'lewy body dementia with behavioral disturbance,' but interviews with nursing staff and the ADON revealed that lewy body dementia alone is not an appropriate diagnosis for antipsychotic use, and staff were aware of the associated risks and black box warning for elderly patients with dementia-related psychosis. Despite the presence of a facility policy stating that psychotropic medications should only be used when nonpharmacological interventions are contraindicated and not for discipline or staff convenience, the medication was continued without clear justification. Staff interviews indicated confusion regarding the appropriateness of the diagnosis for Seroquel, and the DON confirmed that the physician provided the diagnosis but did not clarify the clinical rationale. The resident did not exhibit side effects at the time of review, but the facility did not address the lack of a proper diagnosis for the ongoing use of the antipsychotic medication.

An unhandled error has occurred. Reload 🗙